Www.hsrd.research.va.gov
The objective in this particular study was to examine erythropoiesis stimulating agents in lung and colon cancer patients getting chemotherapy. ESAs are drugs used to treat anemia in cancer. There was a black box warning that was put forward by the FDA for these drugs in 2007. There were increasing restrictions on their use during that time period. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- aapro m extermann m repetto l
- pharmacology—chemotherapy and supportive care
- possible side effects of docetaxel national cancer institute
- registration status pharmaceutical benefits scheme pbs
- cancer outline buffalo academy of veterinary medicine
- hackensack university medical center
- cmn erythropoiesis stimulating agents